Heart rate variability and clinical cardiology.

por Amadi, A, Coats, A J
Publicado 1994

Visual field defects associated with vigabatrin monotherapy in children

por LUCHETTI, A., AMADI, A., GOBBI, G., BERTANI, G.
Publicado 2000

Beta adrenoceptor density in the donor heart: a guide to prognosis?

por Chester, M. R., Amadi, A. A., Barnett, D. B.
Publicado 1995

Lacrimal Gland Changes on Orbital Imaging after Glaucoma Drainage Implant Surgery

por Jacobs, Sarah M., Mudumbai, Raghu C., Amadi, A.J.
Publicado en J Ophthalmic Vis Res (2018)

From trench fever to endocarditis

por Mann, P, Nye, F, Williams, G, Walker, A, Amadi, A
Publicado 2003

ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease.

por Henein, M. Y., Amadi, A., O'Sullivan, C., Coats, A., Gibson, D. G.
Publicado 1996

Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure.

por Stevenson, R N, Keywood, C, Amadi, A A, Davies, J R, Patterson, D L
Publicado 1991

Ocular injuries from fireworks: the 11-year experience of a US level I trauma center

por Chang, I T, Prendes, M A, Tarbet, K J, Amadi, A J, Chang, S-H, Shaftel, S S
Publicado en Eye (Lond) (2016)

Blood Glucose Control and Medication Adherence Among Adult Type 2 Diabetic Nigerians Attending A Primary Care Clinic in Under-resourced Environment of Eastern Nigeria

por Pascal, Iloh GU, Ofoedu, John N, Uchenna, Njoku P, Nkwa, Amadi A, Uchamma, Godswill-Uko E
Publicado 2012

Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.

por McHugh, N J, Csuka, M, Watson, H, Belcher, G, Amadi, A, Ring, E F, Black, C M, Maddison, P J
Publicado 1988

Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of...

por Lee, D., Amadi, A., Sabater, J., Ellis, J., Johnson, H., Kotapati, S., McNamara, S., Walker, A., Cooper, M., Patterson, K., Roskell, N., Meng, Y.
Publicado en Pharmacoecon Open (2018)

Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with...

por Lee, D., Amadi, A., Sabater, J., Ellis, J., Johnson, H., Kotapati, S., McNamara, S., Walker, A., Cooper, M., Patterson, K., Roskell, N., Meng, Y.
Publicado en Pharmacoecon Open (2018)